Certolizumab pegol for induction of remission in Crohn's disease
Appendices
Appendix 1. Search strategies
MEDLINE (inception to date)
1. random$.tw.
2. factorial$.tw.
3. (crossover$ or cross over$ or cross‐over$).tw.
4. placebo$.tw.
5. single blind.mp.
6. double blind.mp.
7. triple blind.mp.
8. (singl$ adj blind$).tw.
9. (double$ adj blind$).tw.
10. (tripl$ adj blind$).tw.
11 assign$.tw.
12. allocat$.tw.
13. randomized controlled trial/
14. or/1‐13
15. (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)
16. 14 not 15
17. exp Crohn disease/ or Crohn*.mp.
18. (inflammatory bowel disease* or IBD).mp.
19. 17 or 18
20. 16 and 19
21. (CDP870 OR 'CDP 870' OR CDP‐870 OR 'certolizumab pegol' OR certolizumab OR cimzia).mp.
22. 20 and 21
EMBASE (inception to date)
1. random$.tw.
2. factorial$.tw.
3. (crossover$ or cross over$ or cross‐over$).tw.
4. placebo$.tw.
5. single blind.mp.
6. double blind.mp.
7. triple blind.mp.
8. (singl$ adj blind$).tw.
9. (double$ adj blind$).tw.
10. (tripl$ adj blind$).tw.
11 assign$.tw..
12. allocat$.tw.
13. crossover procedure/
14. double blind procedure/
15. single blind procedure/
16. triple blind procedure/
17. randomized controlled trial/
18. or/1‐17
19. (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)
20. 18 not 19
21. exp Crohn disease/ or Crohn*.mp.
22. (inflammatory bowel disease* or IBD).mp.
23. 21 or 22
24. 20 and 23
25. exp certolizumab pegol/
26. (CDP870 OR 'CDP 870' OR CDP‐870 OR 'certolizumab pegol' OR certolizumab OR cimzia).mp.
27. 25 or 26
28. 24 and 27
CENTRAL (inception to date)
#1. crohn* OR IBD OR "inflammatory bowel disease*"
#2. CDP870 OR 'CDP 870' OR CDP‐870 OR 'certolizumab pegol' OR certolizumab OR cimzia
#3. #1 and #2
Cochrane IBD Group Specialized Register (inception to date)
#1 (CDP870 OR 'CDP 870' OR CDP‐870 OR 'certolizumab pegol' OR certolizumab OR cimzia).ti.
#2 Crohn.ti.
#3 1 and 2
